New antibody-drug conjugates for lymphoma

New antibody-drug conjugates for lymphoma

VJHemOnc

1 year
148 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Following on from the success of brentuximab vedotin, new antibody-drug conjugates (ADCs) for lymphoma are on the horizon. These successors utilize novel technologies, such as those that allow the determination of how many drugs are attached to the antibody, as well as more potent toxins. In this interview, Graham Collins, MRCP, FRCPath, DPhil, of Oxford University Hospitals NHS Foundation Trust, Oxford, UK, provides an overview of the Phase I study of ADCT-301 for relapsed or refractory Hodgkin and non-Hodgkin lymphoma (NCT02432235). Dr Collins discusses the differences between ADCT-301 and other ADCs, the very promising response rates seen in the trial and toxicities. This video was recorded at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA.
Up Next Autoplay
Lower Costs for Patients in Metastatic Breast Cancer
Lower Costs for Patients in Metastatic Breast Cancer
Category: Breast Cancer
2 Views
ONeal Comprehensive Cancer Center 21 hours
New Technology to Streamline Drug Discovery
New Technology to Streamline Drug Discovery
Category: Other
3 Views
Cancer-News 1 day
Using Technology to Better Understand What Goes Wrong in Cancer
Using Technology to Better Understand What Goes Wrong in Cancer
Category: Breast Cancer
1 Views
Cancer-News 1 day
How Does This Affect Clinicians Today?
How Does This Affect Clinicians Today?
Category: Breast Cancer
2 Views
Cancer-News 1 day
Measuring Chromatin Accessibility: How Reliable is This Data?
Measuring Chromatin Accessibility: How Reliable is This Data?
Category: Breast Cancer
1 Views
Cancer-News 1 day
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Category: Melanoma and Skin Cancer
5 Views
Cancer-News 1 day
Mapping the usual breast development to recognize cancer better
Mapping the usual breast development to recognize cancer better
Category: Breast Cancer
5 Views
Cancer-News 1 day
Metformin: How Does This Affect Treatment?
Metformin: How Does This Affect Treatment?
Category: Ovarian Cancer
6 Views
Cancer-News 1 day
New Frontier Possibility for Preventing Ovarian Cancer
New Frontier Possibility for Preventing Ovarian Cancer
Category: Ovarian Cancer
3 Views
Cancer-News 2 days
"Wild idea" opens possible new boundaries to ovarian cancer prevention
Category: Ovarian Cancer
5 Views
Cancer-News 2 days